Oliver Acton
Company: AstraZeneca
Job title: Associate Principal Scientist
Seminars:
Structure-Based Vaccine & Antibody Discovery at AstraZeneca 9:45 am
- Leveraging Cryo-EM in structure-based design of novel vaccine candidates
- Highlighting structural determination of MoA for neutralising antibodies against respiratory viruses
day: Day 2
Panel Discussion: Evaluating the Wave of Computational & Predictive AI Tools in Structure Prediction to Optimize the Usability & Practicality of the Approaches 5:00 pm
- Focusing on hard to study and hard to drug proteins to navigate the efficacy of tools to predict dynamic proteins
- Using models as a template when processing Cryo-EM, X-Ray Crystallography data to build protein models
- Debating whether in practice structural models can effectively and efficiently predict novel protein interactions to get the most out of the structural data
day: Day 1